Immediate results of the preoperative chemotherapy of breast cancer
Gol'dman, V.G.
Voprosy Onkologii 21(10): 19-22
1975
ISSN/ISBN: 0507-3758 PMID: 810967 Document Number: 88896
Document emailed within 1 workday
Related Documents
Tran, T.M.; Guittard, T.; Duchatelle, V.; Amouroux, J.; Guillevin, L.; Tricoire, J. 1989: Preoperative chemotherapy in breast cancer. Results based on the size of the tumor and multiple foci (95 patients) Annales de Medecine Interne 140(7): 647-648Chmielik, E.; Olszewski, W.P. 2011: Pathologic report of breast cancer after preoperative chemotherapy Polish Journal of Pathology: Official Journal of the Polish Society of Pathologists 62(4 Suppl. 4): S34-S35
Denkert, C.; Schickling, O.; von Minckwitz, G. 2006: Preoperative chemotherapy in breast cancer and the development of new predictive markers Verhandlungen der Deutschen Gesellschaft für Pathologie 90: 114-123
Kurumiya, Y.; Sakamoto, E. 2019: A Case of Breast Cancer That Was Able to Accomplish Six Courses of TAC for Preoperative Chemotherapy Using Pegfilgrastim Gan to Kagaku Ryoho. Cancer and ChemoTherapy 46(7): 1179-1181
Ohta, K.; Dohden, K.; Morishita, M.; Hayashi, H.; Hattori, M.; Hosokawa, O.; Morita, M.; Kaizaki, Y.; Kiya, T. 2006: Clinical examination of safety and effectiveness of primary chemotherapy with CEF followed by docetaxel in preoperative breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 33(2): 199-202
Niu, Z.-H.; Wang, Y.; Chun, B.; Li, C.-X.; Wu, L. 2013: Secretory clusterin (sCLU) overexpression is associated with resistance to preoperative neoadjuvant chemotherapy in primary breast cancer European Review for Medical and Pharmacological Sciences 17(10): 1337-1344
Blohmer, J.U.; Paepke, S.; Kissner, L.; Elling, D.; Fleige, B.; Grineisen, Y.; Lichtenegger, W. 1999: Dose- intensified, preoperative and adjuvant chemotherapy in patients with T3- and T4- breast cancer: toxicity, clinical and pathological remission Zentralblatt für Gynakologie 121(11): 522-525
Kashiwagi, S.; Ishihara, S.; Ishii, M.; Asano, Y.; Watanabe, M.; Morisaki, T.; Aomatsu, N.; Noda, S.; Kawajiri, H.; Nakano, T.; Kawakami, N.; Mitsukawa, Y.; Takashima, T.; Onoda, N.; Ishikawa, T.; Hirakawa, K. 2013: Case of a patient with inflammatory breast cancer who responded to preoperative chemotherapy with paclitaxel plus bevacizumab and could subsequently undergo surgery Gan to Kagaku Ryoho. Cancer and ChemoTherapy 40(12): 2384-2386
Goldobenko, G.V.; Stroganova, L.G.; Firsova, P.P.; Iliukhin, S.A.; Konovalova, V.V. 1979: Remote results of preoperative large fractionation gamma-therapy for breast cancer Voprosy Onkologii 25(12): 67-71
Furmanik, F.; Paprota, K.; Karczmarek-Borowska, B.; Budny, B.; Sawicki, M.; Korobowicz, E.; Zdunek, M.łg.; Jabłonka, A.; Jabłonka, S.ła. 2002: Late results of the combined treatment with the use of preoperative chemotherapy and surgery of locally advanced non-small cell lung cancer Pneumonologia i Alergologia Polska 70(1-2): 34-43
Takiguchi, N.; Souda, H.; Tonooka, T.; Ikeda, A.; Nabeya, Y.; Kainuma, O.; Saito, H.; Arimitsu, H.; Kobayashi, R.; Chibana, T.; Sasaki, K.; Ishige, F.; Nagata, M.; Yamamoto, H.; Denda, T. 2015: The Different Indications and Treatment Effect between Preoperative Chemotherapy and Preoperative Radiotherapy for Advanced Rectal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 42(12): 1475-1478
Marzetti, L.; Framarino Dei Malatesta, M.; Yacoub, M.; Veneziano, M.; Bandiera, A.F.; Fiorelli, C.; Felici, A. 1997: Neoadjuvant chemotherapy in the treatment of breast cancer. Results and prospectives Minerva Ginecologica 49(9): 393-397
Kato, M.; Kinoshita, K.; Sawa, T.; Yoshimitsu, S.; Tomita, F.; Takano, Y.; Segawa, M.; Ohyama, S.; Yonemura, Y.; Miwa, K. 1990: Neoadjuvant chemotherapy of far advanced gastric cancer--effect of preoperative chemotherapy by PMUE (CDDP, MMC, UFT, etoposide Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(3 Part 1): 391-396
Pannuti, F.; Di Marco, A.R.; Rossi, A.P.; Rocchetta, G.; Rubino, I.; Giovannini, M.; Fruet, F. 1981: Sequential hormone-chemotherapy (MAP at high doses and CMF) in metastatic breast cancer. Preliminary results Panminerva Medica 23(2): 93-96
Stamatovic, L.; Susnjar, S.; Gavrilovic, D.; Minic, I.; Ursulovic, T.; Dzodic, R. 2018: The influence of breast cancer subtypes on the response to anthracycline neoadjuvant chemotherapy in locally advanced breast cancer patients Journal of Buon: Official Journal of the Balkan Union of Oncology 23(5): 1273-1280
Donegan, W.L. 1992: Recent trends in the management of breast cancer. 3. Controversies in the use of adjuvant chemotherapy, hormonotherapy and radiotherapy for breast cancer Canadian Journal of Surgery. Journal Canadien de Chirurgie 35(4): 371-377
Galler, A.S.; Bauer, T.L. 2009: A randomised phase II trial of preoperative chemotherapy of cisplatindocetaxel or docetaxel alone for clinical stage IB/II non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG 0204) Yearbook of Oncology 2009: 194-195
Yoneda, A.; Okubo, H.; Okada, K.; Kishikawa, H. 2012: A case of metastatic lung cancer from colon cancer resected successfully after preoperative chemotherapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 39(9): 1419-1422
2006: Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5'-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study Group Anticancer Research 26(1b): 591-597
Muthalib, A.; Darwis, I.; Prayogo, N.; Sutjipto 2000: Preliminary results of multicenter phase Ii trial of docetaxel (Taxotere) in combination with doxorubicin as first line chemotherapy in Indonesian patients with advanced or metastatic breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 498-504